Report - CLINICAL PROTOCOL...Clinical Protocol 0761-014, Amendment 3 Protocol Signature Page Protocol Title: Open-label, Multicenter Phase 112 Study ofMogamulizumab in Combination with Nivolumab

Please pass captcha verification before submit form